Untersuchung von Gedächtnis und körperlicher Aktivität nach Krebsbehandlung bei Überlebenden von Krebserkrankungen von Jugendlichen und jungen Erwachsenen (IMPACT)
This study evaluates relationships among physical activity, thinking, and memory after cancer treatment in survivors of adolescent and young adult cancers.
Studienübersicht
Status
Intervention / Behandlung
Studientyp
Einschreibung (Geschätzt)
Kontakte und Standorte
Studienkontakt
- Name: Clinical Trials Referral Office
- Telefonnummer: 855-776-0015
- E-Mail: mayocliniccancerstudies@mayo.edu
Studieren Sie die Kontaktsicherung
- Name: Melissa Cole
- Telefonnummer: 480-574-4052
- E-Mail: mailto:ARZENL@mayo.edu
Studienorte
-
-
Arizona
-
Scottsdale, Arizona, Vereinigte Staaten, 85259
- Rekrutierung
- Mayo Clinic in Arizona
-
Kontakt:
- Clinical Trials Referral Office
- Telefonnummer: 855-776-0015
- E-Mail: mayocliniccancerstudies@mayo.edu
-
Kontakt:
- Melissa Cole
- Telefonnummer: 480-574-4052
- E-Mail: mailto:ARZENL@mayo.edu
-
Hauptermittler:
- Diane K. Ehlers, PhD
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Probenahmeverfahren
Studienpopulation
Patients with primary diagnosis of cancer when 15-39 years old.
Beschreibung
Inclusion Criteria:
- Adults (aged 18+ years)
- Primary diagnosis of cancer when 15-39 years-old
- Access to a desktop computer or laptop with reliable internet access
- No gross motor impairments that prohibit ambulation
- Willing to complete study requirements
- English speaking
Exclusion Criteria:
- Diagnosed with nonmelanoma skin cancer only
- Not diagnosed with cancer in adolescent and young adult (AYA) age range of 15-39 years
- Scheduled travel during the study period that is not indicative of individual's normal schedule
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Beobachtungsmodelle: CASE_ONLY
- Zeitperspektiven: CROSS_SECTIONAL
Kohorten und Interventionen
Gruppe / Kohorte |
Intervention / Behandlung |
|---|---|
|
Observational
Patients complete questionnaires and cognitive tasks and wear an activity monitor to measure physical activity on study. Some patients may optionally participate in an interview on study. |
Non-Interventional Study |
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Cognitive performance on Stroop task
Zeitfenster: Up to 4 weeks
|
Assessed using the CNS Vital Signs computerized testing platform ("brain games"). CNS Vital Signs is a computerized neuropsychological/neurocognitive assessment platform used by clinicians and researchers to objectively evaluate brain function and neurocognitive status, offering a range of tests and tools for assessment and management of various neurological and behavioral conditions. |
Up to 4 weeks
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Cognitive performance on Visual Memory Test
Zeitfenster: 2 weeks
|
Assessed using the CNS Vital Signs computerized testing platform ("brain games"). CNS Vital Signs is a computerized neuropsychological/neurocognitive assessment platform used by clinicians and researchers to objectively evaluate brain function and neurocognitive status, offering a range of tests and tools for assessment and management of various neurological and behavioral conditions. |
2 weeks
|
|
Cognitive performance on Verbal Memory Test
Zeitfenster: 2 weeks
|
Assessed using the CNS Vital Signs computerized testing platform ("brain games"). CNS Vital Signs is a computerized neuropsychological/neurocognitive assessment platform used by clinicians and researchers to objectively evaluate brain function and neurocognitive status, offering a range of tests and tools for assessment and management of various neurological and behavioral conditions. |
2 weeks
|
|
Cognitive performance on Symbol Digit Coding Test
Zeitfenster: 2 weeks
|
Assessed using the CNS Vital Signs computerized testing platform ("brain games"). CNS Vital Signs is a computerized neuropsychological/neurocognitive assessment platform used by clinicians and researchers to objectively evaluate brain function and neurocognitive status, offering a range of tests and tools for assessment and management of various neurological and behavioral conditions. |
2 weeks
|
|
Cognitive performance on Shifting Attention Test
Zeitfenster: 2 weeks
|
Assessed using the CNS Vital Signs computerized testing platform ("brain games"). CNS Vital Signs is a computerized neuropsychological/neurocognitive assessment platform used by clinicians and researchers to objectively evaluate brain function and neurocognitive status, offering a range of tests and tools for assessment and management of various neurological and behavioral conditions. |
2 weeks
|
|
Cognitive performance on Continuous Performance Test
Zeitfenster: Up to 4 weeks
|
Assessed using the CNS Vital Signs computerized testing platform ("brain games"). |
Up to 4 weeks
|
|
Cognitive performance on Reasoning Test
Zeitfenster: 2 weeks
|
Assessed using the CNS Vital Signs computerized testing platform ("brain games"). CNS Vital Signs is a computerized neuropsychological/neurocognitive assessment platform used by clinicians and researchers to objectively evaluate brain function and neurocognitive status, offering a range of tests and tools for assessment and management of various neurological and behavioral conditions. |
2 weeks
|
|
Cognitive performance on Four Part Continuous Performance Test
Zeitfenster: 2 weeks
|
Assessed using the CNS Vital Signs computerized testing platform ("brain games"). CNS Vital Signs is a computerized neuropsychological/neurocognitive assessment platform used by clinicians and researchers to objectively evaluate brain function and neurocognitive status, offering a range of tests and tools for assessment and management of various neurological and behavioral conditions. |
2 weeks
|
|
Self-reported cognition - FACT-COG
Zeitfenster: 2 weeks
|
Evaluated using the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-COG), a 37-item questionnaire assessing cognitive impairment, cognitive abilities, and quality of life over the past 7 days. Responses are on a 5-point scale (Never; About once a week; Two to three times a week; Nearly every day; Several times a day). Higher scores generally indicate better self-reported cognition. |
2 weeks
|
|
Average weekly minutes of physical activity
Zeitfenster: 2 weeks
|
Moderate-to-vigorous physical activity (MVPA) will be measured using an accelerometer (activPAL) which participants will wear on their non-dominant thigh for 7 consecutive days. |
2 weeks
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Hauptermittler: Diane K. Ehlers, PhD, Mayo Clinic
Publikationen und hilfreiche Links
Nützliche Links
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- 24-008654
- 24-008654 (Andere Kennung: Mayo Clinic Institutional Review Board)
- NCI-2025-01193 (Registrierungskennung: CTRP (Clinical Trial Reporting Program))
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Beschreibung des IPD-Plans
De-identified, limited datasets will be shared with other researchers upon request or according to journal publication requirements
IPD-Sharing-Zeitrahmen
At time of first publication (as required by journals) until last manuscript is published.
IPD-Sharing-Zugriffskriterien
If required by journal and case by case upon request to the PI
Art der unterstützenden IPD-Freigabeinformationen
- STUDIENPROTOKOLL
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .